LPS-based conjugate vaccines composed of saccharide antigens of smooth-type Salmonella enteritidis and rough-type S. gallinarum 9R bound to bovine serum albumin

References

• Konadu E, Shiloach J, Bryla DA, Robbins JB, Szu SC. Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoids, with emphasis on the role of O-acetyls. Infect Immun 1996; 64: 2709–15
   PubMed Web of Science ®Google Scholar
• Levine WC, Buchler JW, Bean H, Tauxe RV. Epidemiology of non-typhoidal Salmonella bacteraemia during the human immunodeficiency virus epidemic. J Infect Dis 1991; 164: 81–7
   PubMed Web of Science ®Google Scholar
• Lepage P, Bogaerts J, van Goethem C, Ntahorutaba M, Nsengumuremui F, Hitimana DG, et al. Community-acquired bacteraemia in African children. Lancet 1987; 1: 1458–61
   PubMed Web of Science ®Google Scholar
• Alshawabkeh K, Yamani MI. Prevalence of Salmonella in poultry farms in Jordan. Dirasat 1996; 23: 67–73
   Google Scholar
• Cooper GL, Venables LM, Nicholas RAJ, Cullen GA, Hormaeche CE. Further studies of the application of live Salmonella enteritidis aro A vaccines in chickens. Vet Rec 1993; 133: 31–6
   PubMedGoogle Scholar
• Bouzoubaa K, Nagaraja KV, Kabbaj FZ, Newman JA, Pomeroy BS. Feasibility of using proteins from Salmonella gallinarum vs 9R live vaccine for the prevention of fowl typhoid in chickens. Avian Dis 1989; 33: 385–91
   PubMed Web of Science ®Google Scholar
• Lindberg AA, Le Minor L. Serology of Salmonella. Methods in Microbiology, T. Bergan. Academic Press. 1984; 15: 1–141
   Google Scholar
• Snoeyenbos GH, Calson VL, Mckie BA, Smyser CF. An epidemiological study of salmonellosis of chickens. Avian Dis 1967; 11: 653–67
   PubMed Web of Science ®Google Scholar
• Humphrey TJ, Meal GC, Rowe B. Poultry meat as a source of human salmonellosis in England and Wales. Epidemiol Infect 1988; 100: 175–84
   PubMed Web of Science ®Google Scholar
• Todd ECD. Poultry-associated food borne disease: its occurrence, cost sources, and prevention. J Food Prot 1980; 43: 129–39
   PubMed Web of Science ®Google Scholar
• Griffin HG. Attenuated Salmonella as live vaccines: prospects for multivalent poultry vaccines. World’ s Poul Sci J 1991; 47: 129–40
   Web of Science ®Google Scholar
• Harbourne JF. The control of fowl typhoid in the field by the use of live vaccine. Vet Rec 1957; 69: 1102–7
   Google Scholar
• Silva EN, Snoeyenbos GH, Weinack OM, Smyser CF. The influence of native gut microflora on the colonization and infection of Salmonella gallinarum in chickens. Avian Dis 1981; 25: 68–73
   PubMed Web of Science ®Google Scholar
• Robbins JB, Schneerson R, Szu SC. Perspective, hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J Infect Dis 1995; 171: 1387–98
   PubMed Web of Science ®Google Scholar
• Yu S, Gu X-X. Synthesis and characterization of lipopolysaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis. Infect Immun 2005; 73: 2790–6
   PubMed Web of Science ®Google Scholar
• Gu X.-X, Tsai C.-M. Preparation, characterization, and immunogenicity of meningococcal lipopolysaccharide-derived oligosaccharide-protein conjugates. Infect Immun 1993; 61: 1873–80
   PubMed Web of Science ®Google Scholar
• Szu SC, Li X-R, Stone AL, Robbins JB. Relation between structure and immunological properties of the Vi capsular polysaccharide. Infect Immun 1991; 59: 4555–61
   PubMed Web of Science ®Google Scholar
• Chu C, Liu B, Watson D, Szu S, Bryla D, Shiloach J, et al. Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid. Infect Immun 1991; 59: 4450–8
   PubMed Web of Science ®Google Scholar
• Verheul AFM, Braat AK, Leenhouts JM, Hoogerhout P, Poolman JT, Snippe H, Verhoef J. Preparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3, 7, 9 phosphoethanolamine group-containing oligosaccharide-protein conjugates. Infect Immun 1991; 59: 843–51
   PubMed Web of Science ®Google Scholar
• Jennings HJ, Lugowski C, Ashton FE. Conjugation of meningococcal lipopolysaccharide R-type oligosaccharides to tetanus toxoid as route to a potential vaccine against group B Neisseria meningitidis. Infect Immun 1984; 43: 407–12
   PubMedGoogle Scholar
• Hellerqvist CG, Lindberg B, Svensson S, Holme T, Lindberg AA. Structural studies on the O-specific chains of the cell wall lipopolysaccharides from Salmonella typhi and S. enteritidis. Acta Chem Scand 1969; 23: 1588–96
   PubMedGoogle Scholar
• Hellerqvist CG, Lindberg B, Svensson S, Holme T, Lindberg AA. Structural studies on the O-specific side chains of the cell wall lipopolysaccharide from Salmonella typhimurium 395ms. Carbohydr Res 1968; 8: 43–55
   Web of Science ®Google Scholar
• Jennings HJ. Capsular polysaccharides as vaccine candidates. Curr Top Microbiol Immunol 1990; 150: 97–127
   PubMed Web of Science ®Google Scholar
• Johnson JA, Joseph A, Morris JG, Jr. Capsular polysaccharide-protein conjugate vaccines against Vibrio cholerae Bengal. Bull Inst Pasteur 1995; 93: 285–90
   Google Scholar
• Svenson SB, Nurminen M, Lindberg AA. Artificial Salmonella vaccine: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium. Infect Immun 1979; 25: 863–72
   PubMed Web of Science ®Google Scholar
• Svenson SB, Lindberg AA. Artificial Salmonella vaccine: Salmonella typhimurium O-antigenic-specific oligosaccharide-protein conjugates elicit protective antibodies in rabbit and mice. Infect Immun 1981; 32: 490–6
   PubMed Web of Science ®Google Scholar
• Masoud H, Urbanik Sypniewska T, Lindner B, Weckesser J, Mayer H. The structure of the lipid A component of Sphaerotilus natans. Arch Microbiol 1991; 156: 167–75
   Google Scholar
• Westphal O, Jann K. Bacterial lipopolysaccharides extraction with phenol-water and further applications of the procedure. Methods Carbohydr Chem 1965; 5: 83–91
   Google Scholar
• Galanos C, Luderitz O, Westphal O. A new method for the extraction of R-lipopolysaccharides. Eur J Biochem 1969; 9: 245–9
   PubMedGoogle Scholar
• Brade H, Galanos C. Isolation, purification, and chemical analysis of the lipopolysaccharide and lipid A of Acinetobacter calcoaceticus NCTC 10305. Eur J Biochem 1982; 122: 233–7
   PubMedGoogle Scholar
• Dubois M, Gales KA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem 1956; 28: 350–6
   Web of Science ®Google Scholar
• Lowry O, Rosebrough J, Farr L, Randall D. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265–75
   PubMed Web of Science ®Google Scholar
• York WS, Darvil AG, McNeil M, Stevenson TT, Albersheim P. Isolation and characterization of plant cell wall components. Methods Enzymol 1985; 118: 3–40
   Web of Science ®Google Scholar
• Galanos C, Luderitz O. Electrodialysis of lipopolysaccharides and their conversion to uniform salt forms. Eur J Biochem 1975; 54: 603–10
   PubMedGoogle Scholar
• Hoogerhout P, Donders E, van Gaans-van den Brink J, Kuipers B, Brugghe H, van Unen A, et al. Conjugates of synthetic cyclic peptides elicit bactericidal antibodies against a conformational epitope on a class 1 outer membrane protein of Neisseria meningitides. Infect Immun 1995; 63: 3473–8
   PubMedGoogle Scholar
• Reed L, Muench H. A simple method of estimating 50% endpoint. Amer J Hyg 1938; 27: 493–7
   Google Scholar
• Cryz S, Furer E, Germanier R. Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and anti-LPS. Infect Immun 1983; 39: 1072–9
   PubMedGoogle Scholar
• Holder I, Wheeler R, Monitce T. Flagellar preparation from Pseudomonas aeruginosa animal protection studies. Infect Immun 1982; 35: 276–80
   PubMedGoogle Scholar
• Specht B, Knapp B, Muth G, Broker M, Hugerer K, Diehl K, et al. Protection of immunocompromized mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins. Infect Immun 1995; 63: 1855–62
   PubMedGoogle Scholar
• Gu X-X, Tsai C-M, Ueyama T, Barenkamp SJ, Robbins JB, Lim DJ. Synthesis, characterization, and immunological properties of detoxified lipopolysaccharide from non-typeable Haemophilus influenzae conjugated to proteins. Infect Immun 1996; 64: 4047–52
   PubMed Web of Science ®Google Scholar
• Gu X-X, Chen J, Barenkamp SJ, Robbins JB, Tsai C-M, Lim DJ, Battey J. Synthesis and characterization of lipopolysachharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis. Infect Immun 1998; 66: 1891–7
   PubMed Web of Science ®Google Scholar